Hugh Smyth

Technologies

• Potent broad-spectrum antiviral for COVID-19 treatment
• High-throughput screening platform for skin penetration and permeability for dermal drugs and skin care products
• Targeted and tunable ophthalmic drug delivery
• Method for dry powder inhaled delivery of clofazimine
• Real-time breath adaptive nebulizer for optimal pulmonary drug delivery
• Advancements in pulmonary antibiotic delivery: innovations for multidrug-resistant infections
• Inhaled formulations of the NSAID indomethacin
• Pegylated aminoglycoside compounds for enhanced treatment of biofilm infections
• Individualized intranasal delivery system for direct pharmaceutical administration to the brain
• Advanced nanoparticle delivery system for targeted pulmonary administration of therapeutic nucleic acids
• Optimized inhalation formulation of clofazimine and amikacin for targeted treatment of respiratory infections